期刊文献+

神经精神性狼疮的预后分析 被引量:1

Analysis of prognosis of neuropsychiatric lupus
下载PDF
导出
摘要 目的探讨影响神经精神性狼疮预后的因素。方法回顾性分析95例住院患者的临床资料,以死亡为阳性结局,对性别、年龄、病程、并发症,狼疮活动指数,实验室检查和治疗措施等36项指标,进行Logistic回归分析,计算OR值及其95%CI。结果95例神经精神性狼疮患者中23例死亡,占24.21%。单因素分析显示,年龄、器质性脑病、脑血管意外、肾功能不全、肝功能损害、心功能不全、合并感染、SLEDAI>30、MRI阳性、CTX冲击治疗、甲基泼尼松龙冲击治疗和MTX/DXM鞘内注射均与NPLE的预后有关。进一步多因素分析发现,脑血管意外、心功能不全以及SLEDAI>30是神经精神性狼疮死亡的独立危险因素;而规则的CTX、甲强龙冲击治疗和MTX/DXM鞘内注射是保护性因素。结论神经精神性狼疮患者合并脑血管意外、心功能不全、和SLEDAI>30提示预后不良;规则运用CTX、甲强龙冲击治疗和MTX/DXM鞘内注射可以减少死亡,改善预后。 Objective To discuss the factors associated with the prognosis of neuropsychiatric lupus (NPLE). Methods A retrospective study on 95 neuropsychiatric lupus inpatients was carried out, and death was outcome factor. The observed variables ineluded gender, age, course of disease, complication, systematic lupus erythematosus disease activity index ( SLEDAI), and other laboratory and therapeutic data. The data were analyzed with the logistic regression. Results 23 patients of the 95 inpatients died , accounted 24.21%. The univariate analysis showed that age, organic brain syndrome, stroke, urinemia, liver dysfunction, heart inefficiency, infection, SLEDAI 〉 30, magnetic resonance imaging positive, pulse cyclophosphamide (CTX) and methylprednisolone therapy, intrathecal dexamethasone and methotrexate were significantly associated with death. While in multivariate analysis, the variables significantly associated with death were stroke, heart inefficiency, SLEDAI 〉 30, plus CTX therapy, methylprednisolone therapy and intrathecal dexamethasone and methotrexate. Conclusion NPLE patients complicated with stroke, heart inefficiency, SLEDAI 〉 30 suggests that there will be an unfavorable prognosis, standardized use of CTX, methylprednisolone therapy and intrathecal dexamethasone/methotrexate can reduce mortality and improve the prognosis.
机构地区 梅州市人民医院
出处 《中国热带医学》 CAS 2006年第7期1296-1297,共2页 China Tropical Medicine
关键词 系统性红斑狼疮 并发症 预后 Systematic lupus erythematosus Neuropsychiatric Complication Prognosis
  • 相关文献

参考文献6

  • 1扶琼,左晓霞,周亚欧,谢艳丽.神经精神狼疮危险因素的临床分析[J].中华风湿病学杂志,2005,9(1):24-27. 被引量:14
  • 2Tan EM,Cohen AS,Fries JF,et al.The 1982 revised criteria for the classification of SLE[J].Arthritis Rheum,1982,25:1271.
  • 3Liang MH,Corzillius M,Bae SC,et al.ACR ad hoc Committee on neuropsychiatric lupus nomenclature.The American College of Rheumatology nosenclature and case definitions for neuropsychiatric lupus syndrome.Arthritis Rheum,1999,42:599 ~ 608.
  • 4Weiner S,Otte A,Schurrmcher M,et al.Diagnosis an d monitoring of cen tral nervous system involvement in systemic lupus erythematosus:value of F-18 fluorodeoxyglucose PET[J].Ann Rheum Dis,2000,59:377 ~ 385.
  • 5Valesini G,Priori R,Francia A,et al.Central nervous system involvement in systemic lupus erythematosus:a new therapeutic approach with intrathecal dexamethasone and methotrexate[J].Ann Rev Immunopathol,1994,16(2):313.
  • 6郭惠芳,靳洪涛,邵福灵,马丽艳,王智慧.中枢神经系统性红斑狼疮的治疗及预后[J].临床荟萃,2003,18(5):266-267. 被引量:1

二级参考文献16

  • 1李玲莉,徐世正,胡萍,朱小瑾,谷沅珉.甲氨喋呤加地塞米松椎管内注射治疗一例狼疮脑病[J].中华皮肤科杂志,1997,30(1):55-55. 被引量:2
  • 2Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in SLE during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore),2003, 82: 299-308.
  • 3Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology, 2001, 57: 496-500.
  • 4Carreno L, Lopez-Longo FJ, Monteagudo I, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus, 1999, 8: 287-292.
  • 5Font J, Cervera R, Ramos-Casals M, et al. Clusters of clinical and immunologic features in systemic lupus erythematosus:analysis of 600 patients from a single center. Semin Arthritis Rheum,2004, 33: 217-230.
  • 6Karassa FB, Ioannidis JP, Touloumi G, et al. Risk factors for central nervous system involvement in systemic lupus erythematosus. Q J Med, 2000, 93: 169-174.
  • 7Tomita M, Khan RL, Blehm BH, et al. The potenOal pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med Hypotheses, 2004, 62: 325-335.
  • 8Janwityanuchit S, Verasertniyom O, Vanichapuntu M, et al. Anti-Sm:its predictive value in systemic lupus erythematosus. Clin Rheumatol, 1993, 12: 350-353.
  • 9Reichlin M. Ribosomal P antibodies and CNS lupus. Lupus,2003, 12: 916-918.
  • 10Afeltra A, Garzia P, Mitterhofer AP, et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibody. Neurology, 2003, 61: 108-110.

共引文献13

同被引文献27

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部